Cosmos Health (NASDAQ:COSM) vs. ScripsAmerica (OTCMKTS:SCRCQ) Critical Contrast

Cosmos Health (NASDAQ:COSM) and ScripsAmerica (OTCMKTS:SCRCQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Risk and Volatility

Cosmos Health has a beta of 5.75, meaning that its stock price is 475% more volatile than the S&P 500. Comparatively, ScripsAmerica has a beta of -0.46, meaning that its stock price is 146% less volatile than the S&P 500.

Profitability

This table compares Cosmos Health and ScripsAmerica’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-38.19%	-5.83%	-3.29%
ScripsAmerica	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Cosmos Health and ScripsAmerica, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	0	0	1	0	3.00
ScripsAmerica	0	0	0	0	N/A

Earnings and Valuation

This table compares Cosmos Health and ScripsAmerica”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$56.45 million	0.27	-$18.54 million	N/A	N/A
ScripsAmerica	N/A	N/A	N/A	N/A	N/A

ScripsAmerica has lower revenue, but higher earnings than Cosmos Health.

Insider & Institutional Ownership

12.6% of Cosmos Health shares are owned by institutional investors. 18.7% of Cosmos Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Cosmos Health beats ScripsAmerica on 5 of the 8 factors compared between the two stocks.

About Cosmos Health

Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

About ScripsAmerica

ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Clifton, New Jersey. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2016.